Researchers in New York are preparing to launch a major study on whether non-psychoactive compounds from the cannabis plant can treat autism.
Starting later this month, they will be running clinical trials on children and teens — some as young as 5-years-old.
The tests will be performed at Montefiore Medical Center and NYU Langone. Researchers at the University of California, San Diego, and the Shaare Zedek Medical Center in Israel also plan to conduct medical marijuana trials on autistic children, as well.
The Big Apple test subjects will range in age from 5 to 18 and have a confirmed diagnosis of moderate to severe autism, according to ClinicalTrials.gov.
Read more
